LIN-12/Notch proteins function as transmembrane receptors for intercellular signals during development. They are activated by binding of their ligands, DSL (Delta/Serrate/LAG-2) proteins. Ligand binding triggers at least one proteolytic processing event in the extracellular domain and then SEL-12/presenilin-dependent proteolysis within the transmembrane domain. This latter event releases the intracellular domain, which translocates to the nucleus and activates transcription of target genes in a complex with LAG-1, SEL-8, and presumably other proteins. The anchor cell (AC)/ventral uterine precursor cell (VU) fate decision has served as an important model for LIN-12/Notch cell signalling events. Constitutive activation of LIN-12, by
lin-12(d) mutations, causes the presumptive AC to be transformed into a VU, resulting in a 0AC-Egl (egg-laying defective) phenotype. Reversion of the 0AC phenotype yields intragenic and extragenic suppressor mutations. Such reversion screens have been carried out on a large scale, using EMS, and more recently, RNAi (Greenwald et al., 1983, Tax et al., 1997; L. Vallier, I. Katic, J. C., C. Bais and I. G., unpublished observations). Extragenic suppressors have defined sel genes (suppressor/enhancer of
lin-12 ), and many sel genes have proven to encode critical components of LIN-12/Notch signal transduction. We have been focusing on two genes,
sel-7 and
sel-13. Loss of
sel-7 activity does not cause any overt phenotypes in an otherwise wild-type background. However,
sel-7 reduces
lin-12 activity in the AC/VU decision, and also affects a subset of other cell fate decisions mediated by
lin-12 and
glp-1.
sel-7encodes a novel protein that has clear orthologs in other nematodes but not in other phyla. A GFP-tagged SEL-7 protein localizes to the nucleus. SEL-7 itself does not appear to interact physically with known nuclear components of the LIN-12 pathway, but another novel protein that interacts with SEL-7 also appears to interact with SEL-8 (a known nuclear component). This result, along with the genetic interactions we have observed, would be consistent with a role for SEL-7 as part of the transcriptional activation complex formed upon LIN-12 activation. Our genetic and molecular analysis of
sel-13 has paralleled our analysis of
sel-7. Loss of
sel-13 activity also reduces
lin-12 activity in the AC/VU decision. SEL-13 also appears to be a nuclear protein, but we have not yet been able to detect any physical interactions with known nuclear components of the LIN-12 pathway.